Insider Transactions Reported by 21 Insiders of Niagen Bioscience, Inc.

Symbol
NAGE on Nasdaq
Location
Los Angeles, CA

Insiders trading volume in the past year

Niagen Bioscience, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Chau Hoi Shuen Solina Holly 10%+ Owner $27,205,042 30 Sep 2022
Champion River Ventures Ltd Director, 10%+ Owner $16,086,288 06 Sep 2023
Frank L. Jaksch Jr. Director $14,351,633 24 Jun 2025
Robert N. Fried Chief Executive Officer, Director $5,434,202 19 Feb 2026
Ozan Pamir Chief Financial Officer $65,414 +$45,616 +230% 19 Feb 2026
Brianna Gerber Chief Financial Officer $40,431 22 Feb 2024
Carlos Luis Lopez SVP, General Counsel $17,693 19 Feb 2026
Li Ka Shing 10%+ Owner $0 06 Sep 2023
Kristin Patrick Director $0 24 Jun 2025
Stephen A. Block Director 17 Jun 2021
Jeong James Lee Interim CFO 16 Jul 2024
Kurt A. Gustafson Director 17 Jun 2021
Jeff Baxter Director 17 Jun 2021
Tsz Ho Tony Lau Director 17 Jun 2021
Kevin M. Farr Chief Financial Officer 12 Aug 2022
Caroline S. Levy Director 01 Dec 2021
Steven D. Rubin Director 24 Jun 2025
Ann Cohen Director 24 Jun 2025
Wang Yu Gary Ng Director 24 Jun 2025
Wing Tak Wendy Yu Director 24 Jun 2025
Hamed Shahbazi Director 24 Jun 2025

Recent Insider Transactions by Companies or Individuals for Niagen Bioscience, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Carlos Luis Lopez NAGE Employee Stock Options (right to buy) Award 41,420 41,420 19 Feb 2026 Direct
Ozan Pamir NAGE Employee Stock Options (right to buy) Award 62,131 62,131 19 Feb 2026 Direct
Robert N. Fried NAGE Employee Stock Options (right to buy) Award 503,937 503,937 19 Feb 2026 Direct
Ozan Pamir NAGE Common Stock Purchase $15,210 $6.85 2,220 2,220 14 Nov 2025 The reported securities are held by the reporting person's spouse.
Ozan Pamir NAGE Common Stock Purchase 153.6% $30,406 $6.81 4,465 7,372 14 Nov 2025 Direct
Hamed Shahbazi NAGE Stock Option (right to buy) Award 20,000 20,000 24 Jun 2025 Direct
Wing Tak Wendy Yu NAGE Stock Option (right to buy) Award 20,000 20,000 24 Jun 2025 Direct
Kristin Patrick NAGE Stock Option (right to buy) Award 20,000 20,000 24 Jun 2025 Direct
Steven D. Rubin NAGE Stock Option (right to buy) Award 20,000 20,000 24 Jun 2025 Direct
Wang Yu Gary Ng NAGE Stock Option (right to buy) Award 20,000 20,000 24 Jun 2025 Direct
Ann Cohen NAGE Stock Option (right to buy) Award 20,000 20,000 24 Jun 2025 Direct
Frank L. Jaksch Jr. NAGE Stock Option (right to buy) Award 20,000 20,000 24 Jun 2025 Direct
Robert N. Fried NAGE Common Stock Options Exercise 6.86% 66,667 1,038,981 09 Apr 2025 Direct
Robert N. Fried NAGE Stock Options (right to buy) Options Exercise -100% -66,667 0 09 Apr 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.